TempraMed Announces Continuance into Ontario
Vancouver, British Columbia--(Newsfile Corp. - April 29, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce that it has continued out of the provincial jurisdiction of British Columbia under the Business Corporations Act (British Columbia) into the provincial jurisdiction of Ontario under the
Technologies, Biotechnologies, Pharmaceutique, Santé
2026-04-29 4:30 PM EDT | TempraMed Technologies Ltd.
Bachem Annual General Meeting 2026
Bubendorf, Switzerland--(Newsfile Corp. - April 29, 2026) - Bachem Holding AG (SIX: BANB) (“Bachem”) announced today that its Annual General Meeting 2026 has approved all proposals of the Board of Directors. A total of 78,3% of the 74‘977‘940 eligible shares were present. The Annual General Meetin
Biotechnologies, Produits chimiques, Soins de santé et hôpitaux, Pharmaceutique
2026-04-29 12:09 PM EDT | Bachem Holding AG
BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 29, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a leader in Botanical Synthesis™ technology, today announced a s
Biotechnologies, Pharmaceutique, Santé
2026-04-29 8:30 AM EDT | BioHarvest Sciences Inc.
Herbal Dispatch Provides Market Update on Launch of First Edible Brand: Chomp Edibles
Vancouver, British Columbia--(Newsfile Corp. - April 28, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a cannabis e-commerce and distribution platform, today announced the launch of its first dedicated edibles brand, Chomp Edibles ("Chomp"), marking a strategic expansion into one of the fastest-growing segments of the Canadian cannabis market. Chomp represents a focus
Pharmaceutique, Cannabis, Dispensaires de cannabis
2026-04-28 3:01 AM EDT | Herbal Dispatch Inc.
InMed Pharmaceuticals Amends Preferred Investment Options
Vancouver, British Columbia--(Newsfile Corp. - April 27, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announces that it has entered into amending agreements in respect of preferred investment options previously entered into with each of Sabby Volatility Warrant Master Fund, Ltd.
Biotechnologies, Pharmaceutique
2026-04-27 5:30 PM EDT | InMed Pharmaceuticals
Herbal Dispatch Advances U.S. Strategy amid Historic Cannabis Rescheduling Shift
Vancouver, British Columbia--(Newsfile Corp. - April 27, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), provides an update on recent regulatory developments in the United States relating to the proposed rescheduling of cannabis under the Controlled Substances Act. The U.S. Department of Health and Human Services has recommended that cannabis be reclassified from Schedule I to Schedule III, a move th
Pharmaceutique, Cannabis, Dispensaires de cannabis
2026-04-27 3:01 AM EDT | Herbal Dispatch Inc.
Bachem Secures Financing of Strategic Growth Initiatives
Bubendorf, Switzerland--(Newsfile Corp. - April 27, 2026) - Bachem Holding AG (SIX: BANB) (“Bachem”) announced today the closing of a revolving credit facility of C
Biotechnologies, Produits chimiques, Soins de santé et hôpitaux, Pharmaceutique
2026-04-27 1:03 AM EDT | Bachem Holding AG
Defence Therapeutics Announces Grant of Restricted Stock Units
Montreal, Quebec--(Newsfile Corp. - April 24, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, wishes to announce that the board of directors of the Company approved the grant of 200,000 incentive restricted stock units ("RSUs") to Mr. Sebastien Plouffe, CEO and Director of the Company, vesting immediately. Each RSU entitles the
Biotechnologies, Pharmaceutique, Santé
2026-04-24 6:30 PM EDT | Defence Therapeutics Inc.
Herbal Dispatch Reports Q4 2025 Gross Sales of $6.2 Million, Achieves Positive Adjusted EBITDA, and Reports Full Year Gross Sales of $16.5 Million
Vancouver, British Columbia--(Newsfile Corp. - April 24, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), announces its financial results for the fourth quarter and year ended December 31, 2025. Q4 2025 HIGHLIGHTS Gross sales of $6.2 million, representing a 115% increase compared to $2.9 million in Q4 2024 Net revenue of $4.1 million (excluding excise
Pharmaceutique, Cannabis, Dispensaires de cannabis
2026-04-24 3:01 AM EDT | Herbal Dispatch Inc.
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
King of Prussia, Pennsylvania--(Newsfile Corp. - April 23, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will provide an overview of the Company's INTASYL siRNA platform and discuss recent clinical progress and priorities,
Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-04-23 7:00 AM EDT | Phio Pharmaceuticals Corp.
Optimi Health Files LIFE Offering Document in Connection with NASDAQ Listing
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that further to its press release dated March 16, 2026, it intends to complete a portion of its previously announced offering of common shares (the "Offering") in Canada pursuant to the Listed Issuer Financing Exemption c
Biotechnologies, Pharmaceutique, Santé, Psychédéliques
2026-04-23 7:00 AM EDT | Optimi Health Corp.
Herbal Dispatch Welcomes the Honourable Herb Dhaliwal as Full-Time Chairman
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a leading cannabis e-commerce and distribution platform, is pleased to announce the appointment of the Honourable Herb Dhaliwal, PC, as a full-time Board Member and Chairman of the Board. The Honourable Herb Dhaliwal, brings a wealth of experience in public service, business, and leadership to Her
Pharmaceutique, Cannabis, Dispensaires de cannabis
2026-04-23 3:01 AM EDT | Herbal Dispatch Inc.
Unbuzzd Wellness Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant
Vancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzdTM ("unbuzzd") — the scientifically-proven and game-changing beverage proven to accelerate alcohol metabolism, restore mental clarity and reduce hangover symptoms, is pleased to announce the appointment of Mr. Richard Buzbuzian as Chief Executive Officer. This marks a pivotal milestone in the Company's commer
2026-04-22 9:01 AM EDT | Unbuzzd Wellness Inc.
PreveCeutical Announces Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce a non-brokered private placement (the "Offering") of up to 40,000,000 units (each, a "Unit") in the capital of the Company at a price of $0.
Biotechnologies, Pharmaceutique, Santé
2026-04-22 3:00 AM EDT | PreveCeutical Medical Inc.
Gregory Esemplare Appointed Chief Operating Officer of HarmonyRx
New York, New York--(Newsfile Corp. - April 21, 2026) - HarmonyRx today announced the appointment of Gregory Esemplare as Chief Operating Officer (COO). In this role, Greg will oversee operations across the organization, with a focus on driving alignment, enhancing execution and supporting continued growth in pharmacy benefits. Greg brings extensive experience in healthcare services, pharmacy benefits and client-focused operations. He previously served in a senior le
2026-04-21 8:25 AM EDT | HarmonyRx
PharmaTher Highlights Strategic Ketamine Opportunity Following New U.S. Executive Order on Psychedelic Treatments for Serious Mental Illness
Toronto, Ontario--(Newsfile Corp. - April 21, 2026) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) ("PharmaTher" or the "Company"), a specialty pharmaceutical company, today announced that it believes the recent U.S. executive order, "Accelerating Medical Treatments
Biotechnologies, Pharmaceutique
2026-04-21 8:00 AM EDT | PharmaTher Holdings Ltd.
Herbal Dispatch Announces Receipt of U.S. DTC Eligibility and Engagement of Market Maker
Vancouver, British Columbia--(Newsfile Corp. - April 21, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a leading cannabis e-commerce and distribution platform, is pleased to announce that the Company's common shares are now eligible for electronic clearing and settlement through the Depository Trust Company ("DTC"). DTC eligibility significantly enhances accessibility for U.S.-based investor
Pharmaceutique, Cannabis, Dispensaires de cannabis
2026-04-21 3:01 AM EDT | Herbal Dispatch Inc.
Richards Group Inc. Announces April 2026 Dividend
Toronto, Ontario--(Newsfile Corp. - April 20, 2026) - Richards Group Inc. (TSX: RIC) (the "Company") announced today its cash dividend for the month ended April 30, 2026 of Cdn$0.11 per share. This dividend will be to shareholders of record at the close of business on April 30, 2026 and will be payable on May 14, 2026. Shareholders who are non-residents of Canada may be required to pay all withholding taxes payable in respect of any dividends of income by the Company, whether such dividends
Soins de santé et hôpitaux, Produits ménagers / de consommation / cosmétiques, Pharmaceutique
2026-04-20 10:24 AM EDT | Richards Group Inc.
Nextleaf Advances Capex-Light Model with New Micro-Processing Site Licence, Supporting Revenue Growth and Margin Expansion
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), a multi-patented life science company and Canadian cannabis processor, is pleased to announce it has been granted a Health Canada Micro-Processing Licence for its second site of operations, Nextleaf Distribution. The issuance of this licence marks a key milestone in the Company's capex-light expansion strategy stre
Biotechnologies, Pharmaceutique, Cannabis, Extracteurs de cannabis
2026-04-20 9:00 AM EDT | Nextleaf Solutions Ltd.
PharmaTher's Microneedle Patch Platforms Positioned to Benefit from Major U.S. Catalysts in Psychedelics and Peptides
Toronto, Ontario--(Newsfile Corp. - April 20, 2026) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) ("PharmaTher" or the "Company"), a specialty pharmaceutical comp
Biotechnologies, Pharmaceutique
2026-04-20 8:00 AM EDT | PharmaTher Holdings Ltd.